文献速递肝病消化内镜

22G叉尖针EUS引导核心肝活检用于NAFLD组织学与脂质组学评估

EUS-guided core liver biopsy sampling using a 22-gauge fork-tip needle: a prospective blinded trial for histologic and lipidomic evaluation in nonalcoholic fatty liver disease.
PubMed 文献 · Gastrointest Endosc · 2019-08-19

前瞻性盲法队列研究纳入基于磁共振弹性成像(MRE)诊断脂肪性肝炎和早期肝纤维化的NAFLD患者,采用22G叉尖核心活检针行EUS引导肝活检(EUS-LB)。所有样本均足以计算NAFLD活动度评分和纤维化分期,并提供足够组织进行脂质组学分析;

要点

  • 22G叉尖针EUS-LB在NAFLD患者中可行,所有样本均足以评估NAS和纤维化分期。
  • EUS-LB在13例MRE分类为正常的病例中确立了早期纤维化。

核心结论

  • EUS-LB采样是NAFLD全面评估的可行技术,在确立非酒精性脂肪性肝炎伴早期纤维化诊断方面可能优于MRE。

研究设计与样本

  • 前瞻性队列研究,纳入基于MRE诊断脂肪性肝炎和早期肝纤维化的NAFLD患者,使用22G叉尖核心活检针行EUS-LB采样,样本由盲法病理学家评估,并与MRE比较。

主要发现

  • 每份TASL中完整门管区中位数为26个(四分位距7-62)。
  • 100%的样本足以传达NAFLD活动度评分和纤维化分期,所有样本均提供足够核心肝组织用于脂质组学检测。
  • 与MRE相比,EUS-LB在13例MRE分类为正常的病例中确立了早期纤维化;EUS-LB相关不良事件发生率为7%,仅限于术后疼痛。

关键数值与推荐

  • 中位TASL为2.4 cm(四分位距2.00-2.75)。
  • 每份TASL中完整门管区中位数为26个(四分位距7-62)。
  • EUS-LB相关不良事件发生率为7%,仅限于术后疼痛。

临床怎么用

  • EUS-LB采样可用于NAFLD的全面评估,包括组织学评分、纤维化分期和脂质组学分析。
  • 在MRE分类为正常的病例中,EUS-LB可能确立早期纤维化诊断。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Diagnostic tools for nonalcoholic fatty liver disease (NAFLD) detection and prognostication are limited, with histology remaining the criterion standard. We evaluated the feasibility and safety of EUS-guided liver biopsy (EUS-LB) sampling in NAFLD staging. METHODS: In a prospective cohort of NAFLD patients with steatohepatitis and early liver fibrosis based on magnetic resonance elastography (MRE), EUS-LB sampling procedures were performed using a 22-gauge fork-tip core biopsy needle. Samples were evaluated by a blinded pathologist. Total aggregate sample length (TASL), number of complete portal triads, ability to calculate NAFLD activity score, ability to stage liver fibrosis, and ability to provide enough core liver tissue for lipidomics analysis were evaluated. Performance of EUS-LB sampling was compared with MRE. RESULTS: Forty-one EUS-LB samples were obtained. The median TASL was 2.4 cm (interquartile range, 2.00-2.75). The median number of complete portal triads per TASL was 26 (interquartile range, 7-62). Of the samples, 100% were adequate to convey NAFLD activity score and fibrosis stage. All samples provided enough core liver tissue to allow the application of lipidomics testing. A significant positive linear association between EUS-LB sampling-detected fibrosis and MRE-detected fibrosis was observed (r = .469, P < .005). Compared with MRE, EUS-LB sampling established early fibrosis in 13 cases that MRE classified as normal. EUS-LB sampling-related adverse events occurred in 7% and were restricted to postprocedural pain. CONCLUSIONS: EUS-LB sampling is a viable technique for full NAFLD evaluation and may be superior to MRE in establishing the diagnosis of nonalcoholic steatohepatitis with early fibrosis. (Clinical trial registration number: NCT02880189.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Bazerbachi F, Vargas EJ, Matar R, et al. EUS-guided core liver biopsy sampling using a 22-gauge fork-tip needle: a prospective blinded trial for histologic and lipidomic evaluation in nonalcoholic fatty liver disease. Gastrointest Endosc. 2019. PMID: 31437454. doi:10.1016/j.gie.2019.08.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。